Company profile: HeartSciences
1.1 - Company Overview
Company description
- Provider of AI-based ECG technology, offering the MyoVista wavECG Device, a 12-lead resting electrocardiograph using wavelet signal processing and AI to detect cardiac dysfunction, including LV relaxation abnormalities; the MyoVista Energy Waveform, for visual context and assessing signal quality issues (not for clinical assessment); and the MyoVista wavECG LV Relaxation Algorithm indicating levels of LV relaxation abnormality.
Products and services
- MyoVista wavECG LV Relaxation Algorithm: AI-based tool that analyzes ECG signals to indicate the level of LV relaxation abnormality, outputting a continuum from highly negative to highly positive
- MyoVista wavECG Device: Wavelet-based 12-lead resting electrocardiograph that leverages AI to detect cardiac dysfunction, including LV relaxation abnormalities, expanding ECG clinical usefulness
- MyoVista Energy Waveform: Non-diagnostic visualization of energy distribution across cardiac electrical activity, offering visual context and highlighting signal quality issues for device users, without supporting clinical assessment
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to HeartSciences
Portola Pharmaceuticals
HQ: United States
Website
- Description: Provider of biopharmaceutical therapeutics, discovering and developing treatments for acute and chronic cardiovascular and autoimmune/inflammatory diseases, including PRT054021, an oral factor Xa inhibitor for prevention and treatment of deep vein thrombosis and pulmonary embolism after orthopedic.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Portola Pharmaceuticals company profile →
Centese
HQ: United States
Website
- Description: Provider of cardiothoracic post-operative medical equipment for surgical care and patient monitoring, including Thoraguard, a compact all-in-one system with digital monitor, suction control, canister, and chest tubes. Features automated chest tube clog clearance, precise digital air leak rate monitoring, hourly drainage volume trends, and self-monitoring alerts for cardiac and thoracic surgery.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Centese company profile →
CeloNova BioSciences
HQ: United States
Website
- Description: Provider of interventional cardiology and endovascular products, including Polyzene-F nano-thin biomimetic coatings for implants to reduce thrombogenicity, inflammation and promote rapid healing; Xero-Gel drug-coated PTCA balloons for small vessel stenosis, restenosis and bifurcations; and COBRA PzF NanoCoated non-drug eluting coronary stents for patients with a short 1-month dual antiplatelet therapy requirement. Offers partnership and co-development opportunities.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CeloNova BioSciences company profile →
BTG
HQ: United Kingdom
Website
- Description: Provider of interventional medicine, pharmaceuticals, and licensing solutions, acquiring, developing, manufacturing, and commercializing products globally. Interventional oncology offerings include beads and TheraSphere Y-90 Glass Microspheres for HCC; other devices include Jetstream Atherectomy System, Vercise Genus DBS, Varithena 1% foam, WaveWriter Alpha SCS, and AcuPulse DUO CO2 Laser.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BTG company profile →
Corthera
HQ: United States
Website
- Description: Provider of biopharmaceutical acquisition, development and commercialization of therapies for illnesses in the acute care setting; lead product candidate relaxin is being evaluated in a global phase 2/3 clinical trial for acute decompensated heart failure.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Corthera company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for HeartSciences
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to HeartSciences
2.2 - Growth funds investing in similar companies to HeartSciences
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for HeartSciences
4.2 - Public trading comparable groups for HeartSciences
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →